Back
ESC2025 Premium Access

Prognostic comparison between implantable cardioverter-defibrillator and amiodarone in cancer patients

Session: New perspectives in cardiology (3) - Ventricular arrhythmias
Topic: Implantable Cardioverter-Defibrillator (ICD)
Speaker: Mr H. Kida (Osaka, JP)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Mr Hirota Kida

Osaka International Cancer Institute, Osaka (Japan)
0 follower

10 more presentations in this session

Discussant - Ventricular arrhythmias

Access
Like
Thumbnail

Influence of minimized atrial pacing on risk of ventricular arrhythmias in patients with pacemakers due to sinus node dysfunction

Speaker: Mr F. Mikkelsen (Risskov, DK)

Access
Abstract
Like
Thumbnail

Sex differences in indications, complications and outcomes of de novo implantable cardioverter defibrillator and cardiac resynchronization therapy: with a focus on diabetes status

Speaker: Miss Y. Zhou (Stockholm, SE)

Access
Abstract
Video
Like
Thumbnail

Wearable cardioverter-defibrillator compared to beta blockers in patients at risk of sudden death: a real-world propensity score-matched study.

Speaker: Professor L. Fauchier (Tours, FR)

Access
Abstract
Video
Like
Thumbnail

Indications, prognosis, and complications of de novo implantable cardioverter defibrillators in patients with type 2 diabetes and without diabetes

Speaker: Miss Y. Zhou (Stockholm, SE)

Access
Abstract
Video
Like
Thumbnail

Access the full session

New perspectives in cardiology (3) - Ventricular arrhythmias

Speakers: Mr H. Kida, Mr F. Mikkelsen, Miss Y. Zhou, Professor L. Fauchier, Miss Y. Zhou
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources